Open Access Repository

Investigating the feasibility and ethical implications of phenotypic screening using stem cell - derived tissue models to detect and manage disease

Downloads

Downloads per month over past year

Harris, AR, Walker, MJ, Gilbert, F ORCID: 0000-0003-0524-8649 and McGivern, P 2022 , 'Investigating the feasibility and ethical implications of phenotypic screening using stem cell - derived tissue models to detect and manage disease' , Stem Cell Reports, vol. 17, no. 1 , pp. 1-10 , doi: 10.1016/j.stemcr.2022.04.002.

[img]
Preview
PDF
149969 - Invest...pdf | Download (835kB)

| Preview

Abstract

Stem-cell-derived tissue models generated from sick people are being used to understand human development and disease, drug development, and drug screening. However, it is possible to detect disease phenotypes before a patient displays symptoms, allowing for their use as a disease screening tool. This raises numerous issues, some of which can be addressed using similar approaches from genetic screenings, while others are unique. One issue is the relationship between disease disposition, biomarker detection, and patient symptoms and how tissue models could be used to define disease. Other issues include decisions of when to screen, what diseases to screen for, and what treatment options should be offered.

Item Type: Article
Authors/Creators:Harris, AR and Walker, MJ and Gilbert, F and McGivern, P
Keywords: ethics, stem cells, phenotypic screening,
Journal or Publication Title: Stem Cell Reports
Publisher: Cell Press
ISSN: 2213-6711
DOI / ID Number: 10.1016/j.stemcr.2022.04.002
Copyright Information:

Copyright 2022 The Author(s)Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)https://creativecommons.org/licenses/by-nc-nd/4.0/

Related URLs:
Item Statistics: View statistics for this item

Actions (login required)

Item Control Page Item Control Page
TOP